New findings shed light on what’s making the parasite less treatable using the drug that’s considered a first line of defense ...

Microorganisms' ability to evolve rapidly has given them a leg up in this microbe-eat-microbe world. As quickly as one organism evolves a defense, another evolves a way to overcome or evade it.

Lately, Dr. Ruth Namazzi and her colleagues have been stopping one another in their hospital ward with worried looks. Between treating patients, she says, they voice their concerns: "'Malaria's very ...

Researchers searching for genetic clues to the growing problem of malaria drug resistance have identified new mutations ...

An international team of researchers has uncovered evidence of partial resistance to artemisinin derivatives -- the primary treatment for malaria -- in young children with severe malaria. Indiana ...

Over 600,000 people worldwide die from mosquito-borne malaria each year, with the majority of these deaths happening among children under 5. Now, there's troubling news that the malaria parasite may ...

More than 600,000 people—predominantly pregnant women and children under the age of five—die from malaria every year. According to the World Health Organization, one child in Africa dies from malaria ...

Across the world, more than 200 million cases of malaria and nearly 500,000 deaths from the disease occur annually—more than 90 percent of which happen in Africa. Children in Africa can be diagnosed ...

Indiana University School of Medicine researchers, in collaboration with colleagues at Makerere University in Uganda, have uncovered evidence of partial resistance to artemisinin derivatives - the ...

The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis announced it was as effective at treating the disease as established treatments.

An experimental bacteria-derived biopesticide is highly effective in killing malaria-carrying mosquitoes, including those that have developed resistance to chemical pesticides, according to initial ...

Transmission-blocking immunity represents a vital component of malaria vaccine strategy, aiming to interrupt the cycle of Plasmodium transmission from humans to mosquitoes. Unlike conventional ...